Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Market Intel: Liquid Biopsies For Cancer Screening – Far From Reach Or Close At Hand?

May 11 2018

• By Jenny Blair

MT1805_Array Blood Samples_135200900_1200.jpg

Related Content

Market Intel: Can New Wave Of Tests Finally Nail Early Diagnosis Of Lung Cancer?

Jan 02 2017

Sophia Genetics' AI Brings In More Standardization To Liquid Biopsies

Jun 26 2017

Start-Up Spotlight: Indi, Liquid Biopsy To Rule Out Lung Cancer

Oct 13 2017

New Chronix Liquid Biopsy Test Could Save Doctors On Immunotherapy Costs

Mar 22 2017

VC Deals Analysis: Liquid Biopsy Summons Yet Another Top A-Lister

Sep 08 2017

Inivata Names New Chief Operations Officer

Sep 12 2017

Abbott Strikes Deal With British Liquid Biopsy Company Angle

Feb 06 2018

Oncimmune Reels In New Strategy Head And More Capital

Mar 27 2018

ANGLE Reels In First Patient For Major US FDA Clinical Study

Apr 05 2018

Oncimmune Kicks Off 2018 With China Pact For Lung Cancer Test

Jan 02 2018

Related Companies

GRAIL Inc.

Chronix Biomedical, Inc.

Inivata Ltd.

Illumina, Inc.

GRAIL Inc.

Epigenomics AG

Freenome Inc.

23andMe, Inc.

Oncimmune Limited

Pathway Genomics Corp.

Biodesix, Inc.

Additional Topics

Commercial Market Intelligence In Vitro Diagnostics Cancer Medical Device

More from In Vitro Diagnostics

More from Diagnostics

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window